Hiring?

E-counselling Series A

West, USA

90% Raised

Short Summary

Wellin5 is a mental health startup that connects the employee with counsellors for online counselling via PC/Mobile. We are quickly growing as the easy alternative to traditional counselling for employees experiencing anxiety, stress & depression.

Overview

Target
US$5,000,000
Minimum
US$100,000
Investment Raised
US$4,500,000
Previous Rounds US$1,000,000
Stage Achieving Sales
Investor Role Any

Highlights

  • Signed on 4 contracts with close to 4M client base.
  • Excellent core team incl. advisor with successful exit in EAP industry
  • 600% revenue growth in 2nd month with 3 sessions on average per client
  • Excellent testimonials from clients and counsellors
  • Quick exit plan with 5-10 times return in 1-3 years through acquisition/IPO
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
16% raised

IMNA Solutions

location_on West, USA

Personalized AI coordinated care navigator Most current oncology-care models can’t effectively manage patients at home IMNA is redefining remote care monitoring to reduce preventable complications and hospital visits for cancer patients.

US$ 3,000,000

Target

US$ 150,000

Min per Investor

Pro
0% raised

Innovative New Wheelchair

location_on Midwest, USA

This innovative electric wheelchair is VERY beneficial! It offers several features not found in existing electric chairs. This includes much more independence, in addition to enhanced safety for both the chair user and those assisting them.

US$ 250,000

Target

US$ 5,000

Min per Investor

Featured
30% raised

Cannabinoid Biotechnology

location_on West, USA

Emerald Health Pharmaceuticals; a biotech company entering Phase 2 human studies with patented unique cannabinoid science & technology focused on diseases like multiple sclerosis and Parkinson's disease; 180+ yrs mgt-team experience; $16M raised.

US$ 10,000,000

Target

US$ 5,000

Min per Investor

load one similar proposal